Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
STROCompany Name
SUTRO BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQSUTRO BIOPHARMA INC - Price to Operating Cash Flow Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
STRO - P/OCF Historical data
| Date | Market Capitalization | Net Cash Flow - Operations | Price to Operating Cash Flow |
|---|---|---|---|
| 6/30/2025 | $ 67.82M | $ -248.86M | 0 |
| 3/31/2025 | $ 80.91M | $ -194.68M | 0 |
| 12/31/2024 | $ 104.72M | $ -191.54M | 0 |
| 9/30/2024 | $ 326.54M | $ -105.73M | 0 |
| 6/30/2024 | $ 263.92M | $ -74.72M | 0 |
| 3/31/2024 | $ 345.99M | $ -115.37M | 0 |
| 12/31/2023 | $ 204.19M | $ -111.62M | 0 |
| 9/30/2023 | $ 126.17M | $ -149.55M | 0 |
| 6/30/2023 | $ 262.69M | $ -50.2M | 0 |
| 3/31/2023 | $ 355.25M | $ -22.19M | 0 |
Key Performance Insights, Last 5 Years
- SUTRO BIOPHARMA INC's latest trailing twelve months (TTM) P/OCF stands at 0.
- Over the past 5 years, SUTRO BIOPHARMA INC's average P/OCF has been 73.2.
- The median P/OCF for SUTRO BIOPHARMA INC during this period was 73.2
- SUTRO BIOPHARMA INC reached its highest P/OCF over the past 5 years at 75.94.
- The lowest P/OCF recorded by SUTRO BIOPHARMA INC in the same timeframe 70.45
SUTRO BIOPHARMA INC's P/OCF vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/OCF Benchmarks
Similar metrics to P/OCF:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Free Cash Flow to Operating Cash Flow - [Calculation] The Free Cash Flow to Cash Flow from Operations ratio, describes how much of a company’s operating cash flow [NCFO] is free to be invested after capital expenditures [CapEx].
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Debt Paydown Yield - [Calculation] The Debt Paydown Yield measures the net change in longterm [Debt] divided by the company’s [MarketCap]. A high debt pay down yield indicates that the business is aggressively paying down debt which increases shareholder [Equity].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of Price to Operating Cash Flow
[Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].Market Cap / CF - Operations
(=) P/OCF P/OCF for SUTRO BIOPHARMA INC is calculated as follows: Market Cap [ $ 556.29M ] / CF - Operations [ $ -62.08M ]
(=) P/OCF [ 0 ] STRO - Price to Operating Cash Flow, Last 5 years
70.45
Minimum
Sep 30, 2022
75.94
Maximum
Dec 31, 2022
73.2
Average
73.2
Median
P/OCF Benchmark AnalysisMarket
The chart above depicts the distribution of P/OCF for companies in the Total Stock Market. The average P/OCF of the companies is 13.1 with a standard deviation of 8.82.
The following table provides additional summary stats:
P/OCF in the Market:
| filtered constituents | 2.56K |
|---|---|
| min | 0.08 |
| max | 42.19 |
| average | 13.1 |
| median | 10.77 |
| std | 8.82 |